We are live on ! Find out more
SC

Samlyn Capital Portfolio holdings

AUM $5.86B
1-Year Est. Return 36.3%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+36.3%
3 Year Est. Return
+115.4%
5 Year Est. Return
+175.71%
10 Year Est. Return
+881.8%
AUM
$4.1B
AUM Growth
-$211M
Cap. Flow
-$415M
Cap. Flow %
-10.12%
Top 10 Hldgs %
31.52%
Holding
170
New
36
Increased
33
Reduced
38
Closed
60

Sector Composition

1 Financials 22.84%
2 Healthcare 17.63%
3 Consumer Discretionary 14.68%
4 Consumer Staples 9.47%
5 Communication Services 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
151
Starbucks
SBUX
$124B
-258,012
Closed -$15.1M
ST icon
152
CALL
Sensata Technologies
ST
$6.46B
-115,000
Closed -$5.02M
STZ icon
153
CALL
Constellation Brands
STZ
$23.2B
-690,000
Closed -$112M
TSCO icon
154
Tractor Supply
TSCO
$16.3B
-285,580
Closed -$3.94M
VMC icon
155
Vulcan Materials
VMC
$38.1B
-171,000
Closed -$20.6M
VRTX icon
156
Vertex Pharmaceuticals
VRTX
$123B
-45,112
Closed -$4.93M
WCN
157
Waste Connections
WCN
$44.3B
-657,300
Closed -$38.7M
WMT icon
158
Walmart Inc
WMT
$915B
-1,767,033
Closed -$42.5M
WSM icon
159
Williams-Sonoma
WSM
$26.9B
-340,774
Closed -$9.14M
XOP icon
160
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.4B
-100,750
Closed -$15.1M
CPAY icon
161
Corpay
CPAY
$24.3B
-67,300
Closed -$10.2M
GAP
162
The Gap Inc
GAP
$7.38B
-590,889
Closed -$14.4M
SC
163
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-1,664,812
Closed -$22.2M
DERM
164
DELISTED
Dermira, Inc.
DERM
-146,000
Closed -$4.98M
ALDR
165
DELISTED
Alder Biopharmaceuticals
ALDR
-181,143
Closed -$3.77M
BIVV
166
DELISTED
Bioverativ Inc. Common Stock
BIVV
-272,800
Closed -$14.9M
HSNI
167
DELISTED
HSN, Inc.
HSNI
-106,719
Closed -$3.96M
PVTB
168
DELISTED
PrivateBancorp Inc
PVTB
-1,084,274
Closed -$64.4M
CSC
169
DELISTED
Computer Sciences
CSC
-711,500
Closed -$49.1M
FMSA
170
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
-1,145,000
Closed -$8.39M

Similar funds

Samlyn Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Samlyn Capital held 170 positions worth $4.1B, down 4.9% from $4.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Samlyn Capital withdrew a net $415M in Q2 2017, closing 60 positions and reducing 38 holdings. Its most notable exit was Aramark, an estimated $99.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Samlyn Capital opened a new position in Lumen worth $80.3M.

  • Samlyn Capital's largest Q2 2017 buy was Lumen: 3,362,246 shares worth $80.3M.
  • Samlyn Capital added most to US Foods in Q2 2017, an estimated $90.4M increase.
  • Samlyn Capital's biggest Q2 2017 reduction was UnitedHealth, cutting an estimated $42.1M.
  • Samlyn Capital fully exited Aramark in Q2 2017, selling an estimated $99.1M.
  • Samlyn Capital's ten largest holdings make up 32% of its $4.1B portfolio in Q2 2017.
  • Samlyn Capital opened 36 new positions and closed 60 in Q2 2017.
  • Samlyn Capital's portfolio value fell 4.9% quarter-over-quarter to $4.1B.

Based on Samlyn Capital's 13F filing for Q2 2017, filed 14 Aug 2017.